1. Home
  2. FLY vs ABCL Comparison

FLY vs ABCL Comparison

Compare FLY & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Firefly Aerospace Inc.

FLY

Firefly Aerospace Inc.

HOLD

Current Price

$22.70

Market Cap

3.5B

Sector

Industrials

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$12.61

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLY
ABCL
Founded
2017
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Military/Government/Technical
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.5B
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
FLY
ABCL
Price
$22.70
$12.61
Analyst Decision
Buy
Strong Buy
Analyst Count
9
5
Target Price
$38.88
$8.40
AVG Volume (30 Days)
2.2M
4.4M
Earning Date
05-04-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
76.71
10.91
EPS
N/A
N/A
Revenue
$159,855,000.00
$75,128,000.00
Revenue This Year
$174.79
N/A
Revenue Next Year
$66.73
$21.85
P/E Ratio
N/A
N/A
Revenue Growth
162.95
160.56
52 Week Low
$16.00
$2.75
52 Week High
$62.17
$13.18

Technical Indicators

Market Signals
Indicator
FLY
ABCL
Relative Strength Index (RSI) 53.01 65.97
Support Level $21.17 $10.38
Resistance Level $23.45 N/A
Average True Range (ATR) 1.32 0.61
MACD 0.16 -0.01
Stochastic Oscillator 83.29 79.02

Price Performance

Historical Comparison
FLY
ABCL

About FLY Firefly Aerospace Inc.

Firefly Aerospace Inc is a space and defense technology company with an established track record of success providing comprehensive mission solutions to national security, government, and commercial customers. The company develops and provides space and defense technologies, including launch vehicles and spacecraft systems, supporting launch, transit, and in-orbit operations for government, commercial, and national security customers. It has only one operating segment. The majority of the company's revenue is derived from Spacecraft Solutions.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: